Vanaudenaerde et al. differentiated between TGF‐β protein levels and mRNA and demonstrated no difference in protein levels, but an increase in TGF‐β mRNA in BOS patients compared to stable LTR [26]. This evidence concerns the gene TGFB1 and Buschke-Ollendorff syndrome.